Endothelin-1 and endothelin B type receptor are induced in mesangial proliferative nephritis in the rat

Ashio Yoshimura, Shigeki Iwasaki, Kiyoko Inui, Terukuni Ideura, Shozo Koshikawa, Masashi Yanagisawa, Tomoh Masaki

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

We studied whether endothelin-1 (ET-1) and its receptor subtypes (ETAR, endothelin A type receptor; and ETBR, B type receptor) were up-regulated in the glomerulus of a rat model of mesangial proliferative glomerulonephritis induced by anti-thymocyte serum (anti-Thy-1 GN). A marked increase in preproET-1 mRNA could be demonstrated in glomerular RNA 3 and six days after disease induction (4.1- and 4.9-fold vs. day 0, respectively), corresponding to the time of mesangial cell proliferation, to the time of macrophage infiltration into glomeruli, and also to the time of increase in glomerular PDGF B-chain mRNA expression. The localization of ET-1 protein in the mesangial area and along the inner aspect of the glomerular capillary wall was also demonstrated by immunohistochemistry from day 3 and maximal at day 6. The major source of the cells expressing ET-1 in glomeruli appeared to be mesangial cells, glomerular endothelial cells and monocyte/macrophages. Furthermore, both gene and protein expression of ET-1 were associated with increased urinary excretion of ET-1. There was no increase in the plasma ET-1 immunoreactivity. Glomerular expression of ETBR mRNA increased in anti-Thy-1 GN (1.5-fold vs. day 0 at day 3 after disease induction, 3.6-fold at day 6 and 2.7-fold at day 10), but there was minimal change in ETAR mRNA expression. These results suggest that preproET-1 mRNA, which is induced in anti-Thy-1 GN, is linked primarily with ETBR mRNA expression. Up-regulated expressions of both preproET-1 mRNA and ET-1 protein, and increased urinary ET-1 excretion in the proliferative phase of anti-Thy-1 GN were dramatically suppressed by complement depletion with cobra venom factor treatment, and these ruled out the possibility that the change of ET-1 might be from the direct effect by anti-Thy-1 antibody itself. In conclusion, there is an induction of glomerular ET-1 and ETBR gene transcription and ET-1 protein synthesis in rat mesangial proliferative glomerulonephritis. PreproET-1 mRNA expression was closely associated with PDGF B-chain mRNA expression and the up-regulation of ET-1 expression may stimulate PDGF-dependent mesangial cell proliferation in anti-Thy-1 nephritis. ET-1 production in glomeruli may allow an amplification of mesangial cell proliferation and subsequent matrix expansion in this model.

Original languageEnglish (US)
Pages (from-to)1290-1297
Number of pages8
JournalKidney International
Volume48
Issue number4
DOIs
StatePublished - 1995

Fingerprint

Endothelin B Receptors
Nephritis
Endothelin-1
Messenger RNA
Mesangial Cells
Endothelin A Receptors
Cell Proliferation
Glomerulonephritis
Proteins
Macrophages
Thymocytes
anti-Thy antibody
Monocytes

ASJC Scopus subject areas

  • Nephrology

Cite this

Endothelin-1 and endothelin B type receptor are induced in mesangial proliferative nephritis in the rat. / Yoshimura, Ashio; Iwasaki, Shigeki; Inui, Kiyoko; Ideura, Terukuni; Koshikawa, Shozo; Yanagisawa, Masashi; Masaki, Tomoh.

In: Kidney International, Vol. 48, No. 4, 1995, p. 1290-1297.

Research output: Contribution to journalArticle

Yoshimura, Ashio ; Iwasaki, Shigeki ; Inui, Kiyoko ; Ideura, Terukuni ; Koshikawa, Shozo ; Yanagisawa, Masashi ; Masaki, Tomoh. / Endothelin-1 and endothelin B type receptor are induced in mesangial proliferative nephritis in the rat. In: Kidney International. 1995 ; Vol. 48, No. 4. pp. 1290-1297.
@article{79b462e17d6b41a9adfe4b057c0c4449,
title = "Endothelin-1 and endothelin B type receptor are induced in mesangial proliferative nephritis in the rat",
abstract = "We studied whether endothelin-1 (ET-1) and its receptor subtypes (ETAR, endothelin A type receptor; and ETBR, B type receptor) were up-regulated in the glomerulus of a rat model of mesangial proliferative glomerulonephritis induced by anti-thymocyte serum (anti-Thy-1 GN). A marked increase in preproET-1 mRNA could be demonstrated in glomerular RNA 3 and six days after disease induction (4.1- and 4.9-fold vs. day 0, respectively), corresponding to the time of mesangial cell proliferation, to the time of macrophage infiltration into glomeruli, and also to the time of increase in glomerular PDGF B-chain mRNA expression. The localization of ET-1 protein in the mesangial area and along the inner aspect of the glomerular capillary wall was also demonstrated by immunohistochemistry from day 3 and maximal at day 6. The major source of the cells expressing ET-1 in glomeruli appeared to be mesangial cells, glomerular endothelial cells and monocyte/macrophages. Furthermore, both gene and protein expression of ET-1 were associated with increased urinary excretion of ET-1. There was no increase in the plasma ET-1 immunoreactivity. Glomerular expression of ETBR mRNA increased in anti-Thy-1 GN (1.5-fold vs. day 0 at day 3 after disease induction, 3.6-fold at day 6 and 2.7-fold at day 10), but there was minimal change in ETAR mRNA expression. These results suggest that preproET-1 mRNA, which is induced in anti-Thy-1 GN, is linked primarily with ETBR mRNA expression. Up-regulated expressions of both preproET-1 mRNA and ET-1 protein, and increased urinary ET-1 excretion in the proliferative phase of anti-Thy-1 GN were dramatically suppressed by complement depletion with cobra venom factor treatment, and these ruled out the possibility that the change of ET-1 might be from the direct effect by anti-Thy-1 antibody itself. In conclusion, there is an induction of glomerular ET-1 and ETBR gene transcription and ET-1 protein synthesis in rat mesangial proliferative glomerulonephritis. PreproET-1 mRNA expression was closely associated with PDGF B-chain mRNA expression and the up-regulation of ET-1 expression may stimulate PDGF-dependent mesangial cell proliferation in anti-Thy-1 nephritis. ET-1 production in glomeruli may allow an amplification of mesangial cell proliferation and subsequent matrix expansion in this model.",
author = "Ashio Yoshimura and Shigeki Iwasaki and Kiyoko Inui and Terukuni Ideura and Shozo Koshikawa and Masashi Yanagisawa and Tomoh Masaki",
year = "1995",
doi = "10.1038/ki.1995.413",
language = "English (US)",
volume = "48",
pages = "1290--1297",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Endothelin-1 and endothelin B type receptor are induced in mesangial proliferative nephritis in the rat

AU - Yoshimura, Ashio

AU - Iwasaki, Shigeki

AU - Inui, Kiyoko

AU - Ideura, Terukuni

AU - Koshikawa, Shozo

AU - Yanagisawa, Masashi

AU - Masaki, Tomoh

PY - 1995

Y1 - 1995

N2 - We studied whether endothelin-1 (ET-1) and its receptor subtypes (ETAR, endothelin A type receptor; and ETBR, B type receptor) were up-regulated in the glomerulus of a rat model of mesangial proliferative glomerulonephritis induced by anti-thymocyte serum (anti-Thy-1 GN). A marked increase in preproET-1 mRNA could be demonstrated in glomerular RNA 3 and six days after disease induction (4.1- and 4.9-fold vs. day 0, respectively), corresponding to the time of mesangial cell proliferation, to the time of macrophage infiltration into glomeruli, and also to the time of increase in glomerular PDGF B-chain mRNA expression. The localization of ET-1 protein in the mesangial area and along the inner aspect of the glomerular capillary wall was also demonstrated by immunohistochemistry from day 3 and maximal at day 6. The major source of the cells expressing ET-1 in glomeruli appeared to be mesangial cells, glomerular endothelial cells and monocyte/macrophages. Furthermore, both gene and protein expression of ET-1 were associated with increased urinary excretion of ET-1. There was no increase in the plasma ET-1 immunoreactivity. Glomerular expression of ETBR mRNA increased in anti-Thy-1 GN (1.5-fold vs. day 0 at day 3 after disease induction, 3.6-fold at day 6 and 2.7-fold at day 10), but there was minimal change in ETAR mRNA expression. These results suggest that preproET-1 mRNA, which is induced in anti-Thy-1 GN, is linked primarily with ETBR mRNA expression. Up-regulated expressions of both preproET-1 mRNA and ET-1 protein, and increased urinary ET-1 excretion in the proliferative phase of anti-Thy-1 GN were dramatically suppressed by complement depletion with cobra venom factor treatment, and these ruled out the possibility that the change of ET-1 might be from the direct effect by anti-Thy-1 antibody itself. In conclusion, there is an induction of glomerular ET-1 and ETBR gene transcription and ET-1 protein synthesis in rat mesangial proliferative glomerulonephritis. PreproET-1 mRNA expression was closely associated with PDGF B-chain mRNA expression and the up-regulation of ET-1 expression may stimulate PDGF-dependent mesangial cell proliferation in anti-Thy-1 nephritis. ET-1 production in glomeruli may allow an amplification of mesangial cell proliferation and subsequent matrix expansion in this model.

AB - We studied whether endothelin-1 (ET-1) and its receptor subtypes (ETAR, endothelin A type receptor; and ETBR, B type receptor) were up-regulated in the glomerulus of a rat model of mesangial proliferative glomerulonephritis induced by anti-thymocyte serum (anti-Thy-1 GN). A marked increase in preproET-1 mRNA could be demonstrated in glomerular RNA 3 and six days after disease induction (4.1- and 4.9-fold vs. day 0, respectively), corresponding to the time of mesangial cell proliferation, to the time of macrophage infiltration into glomeruli, and also to the time of increase in glomerular PDGF B-chain mRNA expression. The localization of ET-1 protein in the mesangial area and along the inner aspect of the glomerular capillary wall was also demonstrated by immunohistochemistry from day 3 and maximal at day 6. The major source of the cells expressing ET-1 in glomeruli appeared to be mesangial cells, glomerular endothelial cells and monocyte/macrophages. Furthermore, both gene and protein expression of ET-1 were associated with increased urinary excretion of ET-1. There was no increase in the plasma ET-1 immunoreactivity. Glomerular expression of ETBR mRNA increased in anti-Thy-1 GN (1.5-fold vs. day 0 at day 3 after disease induction, 3.6-fold at day 6 and 2.7-fold at day 10), but there was minimal change in ETAR mRNA expression. These results suggest that preproET-1 mRNA, which is induced in anti-Thy-1 GN, is linked primarily with ETBR mRNA expression. Up-regulated expressions of both preproET-1 mRNA and ET-1 protein, and increased urinary ET-1 excretion in the proliferative phase of anti-Thy-1 GN were dramatically suppressed by complement depletion with cobra venom factor treatment, and these ruled out the possibility that the change of ET-1 might be from the direct effect by anti-Thy-1 antibody itself. In conclusion, there is an induction of glomerular ET-1 and ETBR gene transcription and ET-1 protein synthesis in rat mesangial proliferative glomerulonephritis. PreproET-1 mRNA expression was closely associated with PDGF B-chain mRNA expression and the up-regulation of ET-1 expression may stimulate PDGF-dependent mesangial cell proliferation in anti-Thy-1 nephritis. ET-1 production in glomeruli may allow an amplification of mesangial cell proliferation and subsequent matrix expansion in this model.

UR - http://www.scopus.com/inward/record.url?scp=0029099587&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029099587&partnerID=8YFLogxK

U2 - 10.1038/ki.1995.413

DO - 10.1038/ki.1995.413

M3 - Article

C2 - 8569091

AN - SCOPUS:0029099587

VL - 48

SP - 1290

EP - 1297

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 4

ER -